
Board Meeting28 Oct 2026, 09:11 pm
Aarti Pharmalabs Board Approves Q2 FY27 Unaudited Results, Appoints New CFO
AI Summary
Aarti Pharmalabs Ltd announced that its Board of Directors, in a meeting held on October 28, 2026, approved the unaudited financial results for the quarter and half-year ended September 30, 2026. The company also disclosed the resignation of its Chief Financial Officer (CFO), Shri Piyush Lakhani, effective October 30, 2026, to pursue other career opportunities. Concurrently, Smt. Vibha Thakkar has been appointed as the new CFO and Key Managerial Personnel, effective October 31, 2026. Smt. Thakkar brings over 18 years of experience in finance across various industries. The financial results and limited review report are available on the company's website.
Key Highlights
- Board approved unaudited financial results for Q2 and H1 FY27.
- CFO Shri Piyush Lakhani resigned to pursue external opportunities.
- Smt. Vibha Thakkar appointed as new CFO effective October 31, 2026.
- New CFO has over 18 years of diverse financial experience.
- Results and auditor's limited review report are publicly available.
Price Impact
More from AARTIPHARM